Literature DB >> 27994951

Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance.

Katsura Niijima1, Yoko Shimoda2, Tsugumichi Saito2, Eijiro Yamada2, Yawara Niijima1, Shuichi Okada2, Masanobu Yamada2.   

Abstract

To assess whether there is any clinical significance for determining the normal range of subcutaneous abdominal fat area, we compared fat area with insulin sensitivity. Visceral and subcutaneous abdominal fat area the L4-L5 thoracic level was determined by computed tomography (CT). Plasma glucose and insulin levels were determined after an overnight fast and calculated by the homeostatic model assessment of insulin resistance (HOMA-IR). We analyzed 350 (180 male and 170 female) subjects whose BMI was 18.5≤BMI<25. The subcutaneous abdominal fat area of the female subjects was 124.7 ± 46.13 cm2 and that of male subjects was 77.53 ± 37.53 cm2 (mean ± SD). We compared HOMA-IR between subjects whose visceral abdominal fat area was above 100 cm2 and subcutaneous abdominal fat area below the mean + 2SD (15 subjects, 6 male and 9 female) with subjects whose visceral abdominal fat area was also above 100 cm2 but whose subcutaneous abdominal fat area was above the mean + 2SD (20 subjects, 7 male and 13 female). The HOMA-IR of the former subjects group was 8.17+/-6.22 and that of the latter subjects group was 3.37+/-2.07 (p = 0.0486). Subjects with increased subcutaneous abdominal fat area displayed lower HOMA-IR values, demonstrating a protective effect of subcutaneous fat for individuals with visceral fat area above 1002 cm.

Entities:  

Keywords:  HOMA-IR; insulin resistance; subcutaneous abdominal fat; visceral abdominal fat

Year:  2016        PMID: 27994951      PMCID: PMC5160386          DOI: 10.1080/21623945.2016.1240138

Source DB:  PubMed          Journal:  Adipocyte        ISSN: 2162-3945            Impact factor:   4.534


  8 in total

Review 1.  Regional adiposity and insulin resistance.

Authors:  Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

2.  Elevated 1-h plasma glucose following 75-g oral glucose load is a predictor of arterial stiffness in subjects with normal glucose tolerance.

Authors:  K Niijima; Y Muranaka; T Ando; S Okada; Y Niijima; K Hashimoto; M Yamada; K Ohshima; M Mori; K Ono
Journal:  Diabet Med       Date:  2012-12       Impact factor: 4.359

3.  Impaired glucose tolerance, but not impaired fasting glucose, is a risk factor for early-stage atherosclerosis.

Authors:  T Ando; S Okada; Y Niijima; K Hashimoto; H Shimizu; T Tsuchiya; M Yamada; K Ohshima; M Mori; K Ono
Journal:  Diabet Med       Date:  2010-12       Impact factor: 4.359

4.  Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study.

Authors:  M B Snijder; M Visser; J M Dekker; B H Goodpaster; T B Harris; S B Kritchevsky; N De Rekeneire; A M Kanaya; A B Newman; F A Tylavsky; J C Seidell
Journal:  Diabetologia       Date:  2005-01-20       Impact factor: 10.122

5.  The visceral adiposity syndrome in Japanese-American men.

Authors:  W Y Fujimoto; S L Abbate; S E Kahn; J E Hokanson; J D Brunzell
Journal:  Obes Res       Date:  1994-07

Review 6.  Pathophysiology and pathogenesis of visceral fat obesity.

Authors:  Y Matsuzawa; I Shimomura; T Nakamura; Y Keno; K Kotani; K Tokunaga
Journal:  Obes Res       Date:  1995-09

7.  Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.

Authors:  M A Banerji; N Faridi; R Atluri; R L Chaiken; H E Lebovitz
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

8.  Abdominal subcutaneous adipose tissue: a protective fat depot?

Authors:  Stacy A Porter; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; Christopher J O'Donnel; Caroline S Fox
Journal:  Diabetes Care       Date:  2009-02-24       Impact factor: 19.112

  8 in total
  2 in total

1.  Screening of exosomal miRNAs derived from subcutaneous and visceral adipose tissues: Determination of targets for the treatment of obesity and associated metabolic disorders.

Authors:  Zheng Yang; Zhuying Wei; Xia Wu; Huidi Yang
Journal:  Mol Med Rep       Date:  2018-07-24       Impact factor: 2.952

2.  Quantitative analyses of adiposity dynamics in zebrafish.

Authors:  Loes M H Elemans; Iris Pruñonosa Cervera; Susanna E Riley; Rebecca Wafer; Rosalyn Fong; Panna Tandon; James E N Minchin
Journal:  Adipocyte       Date:  2019-12       Impact factor: 4.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.